Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H14N4 |
| Molecular Weight | 238.2878 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NC2=C(C=CN2)C(NCC3=CC=CC=C3)=N1
InChI
InChIKey=HPZHFGBKCGWNGN-UHFFFAOYSA-N
InChI=1S/C14H14N4/c1-10-17-13-12(7-8-15-13)14(18-10)16-9-11-5-3-2-4-6-11/h2-8H,9H2,1H3,(H2,15,16,17,18)
| Molecular Formula | C14H14N4 |
| Molecular Weight | 238.2878 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Rolodine (BW 58-271) is a pyrrolopynimidine. This compound has been described in the 1960’s as a potent hypnotic agent and a skeletal muscle relaxant. Rolodine has a local anesthetic effect when applied to the isolated frog sciatic nerve and blocks spontaneous electrical activity (as measured by EEG) lasting for several minutes in cats. No information is available on current use of this central nervous system depressant.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:27:54 GMT 2025
by
admin
on
Mon Mar 31 19:27:54 GMT 2025
|
| Record UNII |
626GMN0STO
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29696
Created by
admin on Mon Mar 31 19:27:54 GMT 2025 , Edited by admin on Mon Mar 31 19:27:54 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5359646
Created by
admin on Mon Mar 31 19:27:54 GMT 2025 , Edited by admin on Mon Mar 31 19:27:54 GMT 2025
|
PRIMARY | |||
|
1866-43-9
Created by
admin on Mon Mar 31 19:27:54 GMT 2025 , Edited by admin on Mon Mar 31 19:27:54 GMT 2025
|
PRIMARY | |||
|
DTXSID30171919
Created by
admin on Mon Mar 31 19:27:54 GMT 2025 , Edited by admin on Mon Mar 31 19:27:54 GMT 2025
|
PRIMARY | |||
|
626GMN0STO
Created by
admin on Mon Mar 31 19:27:54 GMT 2025 , Edited by admin on Mon Mar 31 19:27:54 GMT 2025
|
PRIMARY | |||
|
C152245
Created by
admin on Mon Mar 31 19:27:54 GMT 2025 , Edited by admin on Mon Mar 31 19:27:54 GMT 2025
|
PRIMARY | |||
|
100000084353
Created by
admin on Mon Mar 31 19:27:54 GMT 2025 , Edited by admin on Mon Mar 31 19:27:54 GMT 2025
|
PRIMARY | |||
|
1867
Created by
admin on Mon Mar 31 19:27:54 GMT 2025 , Edited by admin on Mon Mar 31 19:27:54 GMT 2025
|
PRIMARY | |||
|
SUB10369MIG
Created by
admin on Mon Mar 31 19:27:54 GMT 2025 , Edited by admin on Mon Mar 31 19:27:54 GMT 2025
|
PRIMARY | |||
|
106570
Created by
admin on Mon Mar 31 19:27:54 GMT 2025 , Edited by admin on Mon Mar 31 19:27:54 GMT 2025
|
PRIMARY | |||
|
CHEMBL347425
Created by
admin on Mon Mar 31 19:27:54 GMT 2025 , Edited by admin on Mon Mar 31 19:27:54 GMT 2025
|
PRIMARY | |||
|
C011023
Created by
admin on Mon Mar 31 19:27:54 GMT 2025 , Edited by admin on Mon Mar 31 19:27:54 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
